Timeline

Nathalie Jolly
Head of Facility
06 Nov 2020
news

Suivi de la persistance de la réponse immunitaire contre le SARS-CoV-2 au sein de la cohorte de Crépy-en-Valois (COVID-Oise)

Read more
02 Sep 2020
publication

A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

Read more
26 Jun 2020
news

Curie-O-SA : étude de la réponse immunitaire contre le virus SARS-CoV2

Read more
26 Jun 2020
news

Séro-épidémiologie du SARS-CoV-2 (études CORSER)

Read more
25 Jun 2018
project

Institut Pasteur’s commitments for clinical trials

Read more
21 Nov 2015
project

Matinales du CRT

Read more
21 Jul 2015
team

Clinical Core

Read more
09 Jan 2009
publication

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial

Read more
03 Dec 2007
publication

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers

Read more
01 Aug 2003
publication

Increased production of interferon-gamma by Leishmania homologue of the mammalian receptor for activated C kinase-reactive CD4+ T cells among human blood mononuclear cells: an early marker of exposure to Leishmania?

Read more